Model May Predict Rheumatoid Arthritis - CBS News
January 30, 2007 SpiritIndia | Model May Predict Rheumatoid Arthritis CBS News, NY - In an effort to help guide treatment decisions, researchers in the Netherlands have developed a model for predicting a patient's rheumatoid arthritis risk. ... New Score Helps Spot Rheumatoid Arthritis Sufferers Predicting The Risk Of Rheumatoid Arthritis For Early Arthritis ... |
Predicting The Risk Of Rheumatoid Arthritis For Early Arthritis ... - Science Daily (press release)
January 30, 2007SpiritIndia | Predicting The Risk Of Rheumatoid Arthritis For Early Arthritis ... Science Daily (press release) - What Is The Best Treatment Strategy For Early Rheumatoid Arthritis? (October 30, 2005) -- While the recent increase in therapeutic options offers much ... New Score Helps Spot Rheumatoid Arthritis Sufferers Predicting the Risk of Rheumatoid Arthritis for Early Arthritis ... Risk of Joint Pain Developing into Rheumatoid Arthritis Can Be ... |
New Score Helps Spot Rheumatoid Arthritis Sufferers - drkoop.com
January 30, 2007| New Score Helps Spot Rheumatoid Arthritis Sufferers drkoop.com - The problem, said van der Helm-van Mil, is that treatment of rheumatoid arthritis with the rug methotrexate at this point can reduce future joint damage but ... |
Predicting the Risk of Rheumatoid Arthritis for Early Arthritis ... - DG News
January 30, 2007SpiritIndia | Predicting the Risk of Rheumatoid Arthritis for Early Arthritis ... DG News - A wealth of research supports early aggressive treatment with disease-modifying antirheumatic drugs (DMARDs) as the best course for preventing joint damage ... A prediction rule for disease outcome in patients with recent ... |
Source: Company filings Q1:March Q2:June Q3:September Q4:December - 123Jump.com
January 30, 2007 CNNMoney.com | Source: Company filings Q1:March Q2:June Q3:September Q4:December 123Jump.com, FL - REMICADE is a treatment for immune-mediated inflammatory disorders that Schering-Plough markets in countries outside the United States (except in Japan and ... Schering's profit climbs 75% on strong sales of key drugs Schering-Plough Reports Financial Results for 2006 Fourth Quarter ... Schering-Plough Reports Financial Results for 2006 Fourth Quarter ... |
First rheumatology conference aims to stop arthritis in its tracks - Maktoob Business (press release)
January 30, 2007| First rheumatology conference aims to stop arthritis in its tracks Maktoob Business (press release), United Arab Emirates - “Patients are presenting at later stages, which makes treatment less effective and more difficult, and restricted primarily to damage control.” ... |
Wyeth Profit Climbs on Vaccine, Arthritis Treatments (Update2) - Bloomberg
January 30, 2007| Wyeth Profit Climbs on Vaccine, Arthritis Treatments (Update2) Bloomberg - Sales of Enbrel for rheumatoid arthritis and psoriasis rose 40 percent outside the US and Canada, where Wyeth has exclusive marketing rights. ... |
Schering-Plough Fourth Quarter Earnings Call - 123Jump.com
January 30, 2007| Schering-Plough Fourth Quarter Earnings Call 123Jump.com, FL - REMICADE is a treatment for immune-mediated inflammatory disorders that Schering-Plough markets in countries outside the United States (except in Japan and ... |
Predicting the risk of rheumatoid arthritis for early arthritis ... - SpiritIndia
January 30, 2007SpiritIndia | Predicting the risk of rheumatoid arthritis for early arthritis ... SpiritIndia, India - A wealth of research supports early aggressive treatment with disease-modifying antirheumatic drugs (DMARDs) as the best course for preventing joint damage ... A prediction rule for disease outcome in patients with recent ... |
Wyeth Reports Earnings Results for the 2006 Fourth Quarter and ... - PR Newswire (press release)
January 30, 2007| Wyeth Reports Earnings Results for the 2006 Fourth Quarter and ... PR Newswire (press release), NY - Enbrel is a breakthrough product approved for the treatment of chronic inflammatory diseases, including rheumatoid arthritis, juvenile rheumatoid arthritis, ... |
First rheumatology conference aims to stop arthritis in its tracks - AME Info (press release)
January 30, 2007| First rheumatology conference aims to stop arthritis in its tracks AME Info (press release), United Arab Emirates - 'Patients are presenting at later stages, which makes treatment less effective and more difficult, and restricted primarily to damage control.' ... |
Predicting the risk of rheumatoid arthritis for early arthritis ... - EurekAlert (press release)
January 30, 2007| Predicting the risk of rheumatoid arthritis for early arthritis ... EurekAlert (press release), DC - A wealth of research supports early aggressive treatment with disease-modifying antirheumatic drugs (DMARDs) as the best course for preventing joint damage ... |